← FDA Drug Approvals (Drugs@FDA)

GEFITINIB

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: APOTEX · Approved 2022-09-23

Drug application

FDA Application #

ANDA209532

Application type

Abbreviated New Drug Application (Generic)

Brand name

GEFITINIB

Generic name

Gefitinib

Active ingredients

GEFITINIB

Dosage form

TABLET

Route

ORAL

Marketing status

Discontinued

Sponsor

APOTEX

First approval

2022-09-23

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown